companydata.dkcompanydata.dk

ABL BIOTEC A/S: Financial statements 2022

CVR: 50811018

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

ABL BIOTEC A/S (CVR 50811018) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -156,457 and a net result of DKK -2,875,355 compared with DKK 3,731,358 the year before. Equity in the 2022 report amounted to DKK 26,333,063. The solvency ratio was 99.8%. The company had 1 employee in the financial year.

Gross Profit
DKK -156,457
Profit/Loss
DKK -2,875,355
Equity
DKK 26,333,063
Total Assets
DKK 26,386,845
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022--156K-2.9M26.3M1
2021--130K3.7M29.8M1
2020--116K2.5M26.6M1
2019--114K3.3M24.7M1
2018--109K-2M21.5M1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on ABL BIOTEC A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

ABL BIOTEC A/S: The 2021 annual report is outMar 16, 2022

ABL BIOTEC A/S has published its annual report for 2021. Gross profit came to DKK -130,033, and the net result was DKK 3,731,358.

About ABL BIOTEC A/S

ABL BIOTEC A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1974. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named KONTORBUTIKKEN ApS and PAPIR EN GROS VIGGO TRANHOLM MADSEN ApS. The management consists of Asger Bach-Larsen. The board consists of Kirsten Bach-Larsen (chair), Gitte Larsen and Rikke Dahl Andersson. The company is owned by Asger Bach-Larsen and Kirsten Bach-Larsen. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK -129,949 and a net result of DKK -116,723 compared with DKK 3,704,421 the year before. Equity in the 2025 report amounted to DKK 27,884,586.

Source: annual report 2025, Danish Business Authority